Randomized, Double-Blind Study of the Safety of the Liquid Versus Lyophilized Formulation of Palivizumab in Premature Infants and Children with Chronic Lung Disease of Prematurity

INTRODUCTION: To avoid the need for reconstitution required by lyophilized palivizumab, a liquid formulation was developed. This study assessed the safety and antidrug antibodies (ADA) of the liquid formulation of palivizumab compared with the lyophilized formulation. METHODS: This phase 4, randomiz...

Descripción completa

Detalles Bibliográficos
Autores principales: Makari, Doris, Jensen, Kathryn M., Harris, Brian, Jafri, Hasan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2014
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269632/
https://www.ncbi.nlm.nih.gov/pubmed/25156956
http://dx.doi.org/10.1007/s40121-014-0033-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269632/
https://www.ncbi.nlm.nih.gov/pubmed/25156956
http://dx.doi.org/10.1007/s40121-014-0033-y

Ejemplares similares